These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21625299)

  • 1. Hepatitis C-related arthropathy: Diagnostic and treatment considerations.
    Kemmer NM; Sherman KE
    J Musculoskelet Med; 2010 Sep; 27(9):351-354. PubMed ID: 21625299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.
    Zehairy M; Soliman E; Daghaidy A
    Rheumatol Int; 2012 Nov; 32(11):3495-501. PubMed ID: 22068352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatitis C virus-related arthritis.
    Zuckerman E; Yeshurun D; Rosner I
    BioDrugs; 2001; 15(9):573-84. PubMed ID: 11580301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.
    Bombardieri M; Alessandri C; Labbadia G; Iannuccelli C; Carlucci F; Riccieri V; Paoletti V; Valesini G
    Arthritis Res Ther; 2004; 6(2):R137-41. PubMed ID: 15059277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection.
    Orge E; Cefle A; Yazici A; Gürel-Polat N; Hulagu S
    Rheumatol Int; 2010 Feb; 30(4):485-8. PubMed ID: 19547976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection associated arthritis.
    Al-Dahshan MA; Al-Dahshan TA
    J Egypt Soc Parasitol; 2012 Apr; 42(1):33-40. PubMed ID: 22662593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated Peptide frequency in patients with chronic hepatitis C virus infection and effect of presence of systemic disease.
    Albayrak A; Dursun H; Uyanik MH; Cerrah S
    Eurasian J Med; 2012 Dec; 44(3):131-4. PubMed ID: 25610226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy.
    Ezzat WM; Raslan HM; Aly AA; Emara NA; El Menyawi MM; Edrees A
    Rheumatol Int; 2011 Jan; 31(1):65-9. PubMed ID: 19882340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia.
    Liu FC; Chao YC; Hou TY; Chen HC; Shyu RY; Hsieh TY; Chen CH; Chang DM; Lai JH
    Clin Rheumatol; 2008 Apr; 27(4):463-7. PubMed ID: 17876647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection.
    Bassyouni IH; Ezzat Y; Hamdy S; Talaat RM
    Clin Chem Lab Med; 2009; 47(7):842-7. PubMed ID: 19575546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.
    Siloşi I; Boldeanu L; Biciuşcă V; Bogdan M; Avramescu C; Taisescu C; Padureanu V; Boldeanu MV; Dricu A; Siloşi CA
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement.
    Ferri C; Ramos-Casals M; Zignego AL; Arcaini L; Roccatello D; Antonelli A; Saadoun D; Desbois AC; Sebastiani M; Casato M; Lamprecht P; Mangia A; Tzioufas AG; Younossi ZM; Cacoub P;
    Autoimmun Rev; 2016 Dec; 15(12):1145-1160. PubMed ID: 27640316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of rheumatoid arthritis from hepatitis C-related arthropathy: case report.
    Dima-Cozma C; Mitu F; Macovei L; Arhire O; Rezuş E
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):637-42. PubMed ID: 25341277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
    Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic symptoms as presenting manifestations of hepatitis C virus infection.
    Rivera J; Garcia-Monforte A; Núñez-Cortés JM
    J Clin Rheumatol; 1999 Oct; 5(5):268-72. PubMed ID: 19078407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictive value of high-positive rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.
    Lin KM; Chen WM; Tung SY; Wei KL; Shen CH; Chang TS; Chang PJ
    Int J Rheum Dis; 2019 Jan; 22(1):116-120. PubMed ID: 30338656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
    Younossi Z; Park H; Henry L; Adeyemi A; Stepanova M
    Gastroenterology; 2016 Jun; 150(7):1599-1608. PubMed ID: 26924097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis.
    Fusconi M; Vannini A; Dall'Aglio AC; Pappas G; Cassani F; Ballardini G; Frisoni M; Grassi A; Bianchi FB; Zauli D
    Aliment Pharmacol Ther; 2005 Nov; 22(10):951-5. PubMed ID: 16268969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.